Changes in Physician Performance Through Continuous Professional Development

This study has been completed.
Sponsor:
Information provided by:
Henry Ford Health System
ClinicalTrials.gov Identifier:
NCT00115284
First received: June 21, 2005
Last updated: February 12, 2009
Last verified: February 2009
  Purpose

The purpose of this study is to determine whether having physicians evaluate their management of certain diseases as part of board recertification results in improved patient care.


Condition Intervention
Asthma
Health Personnel
Behavioral: ABIM asthma practice improvement module

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: Single Blind
Official Title: An Evaluation of Changes in Physician Performance Through Continuous Professional Development

Resource links provided by NLM:


Further study details as provided by Henry Ford Health System:

Primary Outcome Measures:
  • 1) The proportion of patients prescribed inhaled corticosteroids

Secondary Outcome Measures:
  • 1) The proportion of patients reporting instruction on the proper inhaler technique
  • 2) The proportion of patients reporting that asthma triggers were discussed
  • 3) The proportion of patients instructed to use short-acting beta-agonists as needed.
  • 4) The proportion of patients instructed to use a peak flow meter
  • 5) The proportion of patients who received a written action plan for exacerbations
  • 6) The proportion of patients reporting nocturnal asthma symptoms in the past month
  • 7) The proportion of patients reporting regular use of a rescue inhaler daily.

Estimated Enrollment: 40
Study Start Date: January 2005
Study Completion Date: December 2006
Primary Completion Date: July 2006 (Final data collection date for primary outcome measure)
Detailed Description:

In the year 2000, the American Board of Internal Medicine introduced continuous professional development as part of its board recertification process. The purpose of these changes were to achieve the following goals:

  • To improve the quality of patient care;
  • To affirm the high standards expected of a self-regulating, accountable profession;
  • To foster continuing scholarship and self-improvement;
  • To offer diplomats a portfolio of credentials attesting to competence; and
  • To add value to the health care system.

The most notable change in the new recertification process was the addition of practice improvement modules (PIMs). These modules require physicians to review how well they manage a particular chronic disease within their practice and to develop an improvement plan for their practice. In April 2005, it became a requirement that all internists complete a PIM as part of board recertification.

Currently, it not known whether having physicians evaluate their management of certain diseases as part of board recertification will achieve its intended goal of improving patient care. Therefore, the purpose of this trial is to assess whether practice improvement modules result in improved clinical performance.

The PIM selected for this study will focus on asthma. As PIMs seek to improve the quality of care within a practice, the unit of randomization in this study will be clinics (i.e., practices) within the Henry Ford Health System. We will enroll practicing, board-certified internists within the Henry Ford Medical Group (~40 internists or 20 per arm). Clinics (~16 or 8 per arm) will then be randomized to either complete the PIM or not complete the PIM. Participating internists at a site randomized to complete the PIM will be encouraged to work together to complete the asthma PIM. Participating internists at control sites will continue usual care and will not be asked to complete an asthma PIM.

Comparisons: We will assess differences in asthma care by prospectively surveying patients seen by physicians in the intervention group and control group following the intervention period. These analyses will be adjusted by the baseline characteristics of asthma patients seen by participating physicians.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Previously board-certified in internal medicine
  • Practicing general internist within the Henry Ford Medical Group

Exclusion Criteria:

  • None
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00115284

Locations
United States, Michigan
Henry Ford Health System
Detroit, Michigan, United States, 48202
Sponsors and Collaborators
Henry Ford Health System
Investigators
Principal Investigator: L. Keoki Williams, MD, MPH Center for Health Services Research, Henry Ford Health System
  More Information

Publications:

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00115284     History of Changes
Other Study ID Numbers: F10011
Study First Received: June 21, 2005
Last Updated: February 12, 2009
Health Authority: United States: Institutional Review Board

Keywords provided by Henry Ford Health System:
Asthma
Education, Medical, Continuing
American Board of Internal Medicine
Recertification
Continuous Professional Development
Practice improvement

Additional relevant MeSH terms:
Asthma
Bronchial Diseases
Respiratory Tract Diseases
Lung Diseases, Obstructive
Lung Diseases
Respiratory Hypersensitivity
Hypersensitivity, Immediate
Hypersensitivity
Immune System Diseases

ClinicalTrials.gov processed this record on July 31, 2014